SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-15-000201
Filing Date
2015-04-30
Accepted
2015-04-30 17:15:20
Documents
1
Period of Report
2015-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 04-28-2015 form4.html 4  
1 FORM 4 FOR 04-28-2015 form4.xml 4 4612
  Complete submission text file 0001161697-15-000201.txt   6170
Mailing Address CATALYST PHARMACEUTICAL PARTNERS, INC. 355 ALHAMBRA CIRCLE, SUITE 1500 CORAL GABLES FL 33134
Business Address
MUTH DAVID D (Reporting) CIK: 0001111736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 15820282

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations